Skip to main content

Table 3 Change in biomarkers on treatment

From: Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial

 

Transformation

Trend

Estimates based on the model

p value (not corrected)

Bonferroni adjusted p value

Baseline

Week 6

Week 12

Week 18

Week 24

Hypoxia-related makers

 CA9

Square root

Increase

8.39

13.77

15.43

17.22

13.96

0

<0.0001

 Clusterin

Log

5.08

5.29

5.18

5.24

5.49

0.00042

0.0088

 GLUT1

Log

No significant change

3.9

3.86

3.87

3.87

3.77

0.013

0.35

 Caveolin

Square root

2.65

2.51

2.55

2.53

2.27

0.55

>0.99

 OPN

Log

4.43

4.23

4.18

4.25

4.49

0.27

>0.99

Signaling pathways

 VEGFA

Log

Increase

3.82

4.94

4.96

4.98

4.7

0

<0.0001

 FLT3L

Log

5.31

6.62

6.78

6.51

6.41

0

<0.0001

 AXL

None

5452.58

7689.79

7603.41

7055.92

7348.19

0

<0.0001

 Gas6

Square root

38.54

55.03

50.85

45.67

52.88

0

<0.0001

 c-MET

None

106.04

147.79

142.02

124.13

155.28

7.8E-09

<0.0001

 VEGFR

Log

Decrease

7.32

6.66

6.37

6.37

7.02

1.7E-12

<0.0001

 FLT3

Log

No significant change

3.98

3.71

3.75

3.91

3.84

0.003

0.081

 SCF

Log

4.45

4.36

4.3

4.19

4.72

0.071

>0.99

IGF1R

Log

5.43

5.58

5.6

5.64

5.57

0.035

0.95

 IGFI

None

48,276.42

49,765.76

38,327.24

46,418.15

47,612.38

0.034

0.92

 IGFII

None

149.85

168.03

151.46

147.71

146.22

0.34

>0.99

 HGF

Square root

22.19

18.72

19.45

18.37

22.34

0.06

>0.99

Inflammation

 CRP

Square root

No significant change

91.13

89.21

89.95

94.68

75.03

0.83

>0.99

 IL6

Log

2.93

2.9

2.95

2.97

2.99

0.98

>0.99

Bone-related markers

 

 BSAP

None

Increase

153.54

179.84

175.52

141.5

164.09

0.00024

0.0065

 Trap5b

Log

Decrease

1.44

1.16

1.2

1.16

1.31

0.00002

0.0005

 SEMA3C

Log

No significant change

4.23

4.45

4.35

3.78

3.8

0.22

>0.99

Micro-environment/angiogenesis

 IL8

Log

Increase

2.18

2.49

2.68

2.68

2.78

1.5E-12

<0.0001

 ANG2

Log

Decrease

6.95

6.47

6.48

6.6

6.3

2.5E-08

<0.0001

 TIMP2

None

72.28

65.65

66.34

65.08

62.28

1.2E-06

<0.0001

 TIE2

Log

8.62

8.25

8.1

7.89

8.43

0.00002

0.0005

 Thrombo spondin

Square root

No significant change

64.49

61.72

64.22

49.68

71.9

0.055

>0.99